Peginterferon alfa-2b biosimilar (Amega Biotech)

聚乙二醇干扰素α-2b生物类似药 (Amega Biotech)

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePeginterferon alfa-2b biosimilar (Amega Biotech)

Drug Alias NamePeginterferon alpha-2b biosimilar - Amega Biotech聚乙二醇干扰素α-2b生物仿制药 (Amega Biotech)

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionInterferon alpha/beta receptor agonists

TargetsInterferon alpha/beta receptor

Therapy Area/IndicationsHepatitis C

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Clinical)

Highest Status in ChinaN/A

Originator CompaniesAmega Biotech

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAmega Biotech

Active IndicationsN/A

Inactive IndicationsHepatitis C

ATC CodeL03AB10